|
GB845274A
(en)
*
|
1955-10-06 |
1960-08-17 |
Gen Foods Corp |
Improved gelatin composition
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4657760A
(en)
|
1979-03-20 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Methods and compositions using monoclonal antibody to human T cells
|
|
US4515893A
(en)
|
1979-04-26 |
1985-05-07 |
Ortho Pharmaceutical Corporation |
Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
|
|
EP0040409B1
(de)
|
1980-05-21 |
1984-11-14 |
Siemens Aktiengesellschaft |
Mosaiktafel mit geschlossener Frontseite
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
AU3722984A
(en)
*
|
1984-01-05 |
1985-07-11 |
Manlab Pty. Ltd. |
Reagents for immunoassay at elevated temperatures
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
US5091178A
(en)
|
1986-02-21 |
1992-02-25 |
Oncogen |
Tumor therapy with biologically active anti-tumor antibodies
|
|
EP0545913B1
(en)
|
1986-08-18 |
1999-02-24 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents
|
|
US5183746A
(en)
|
1986-10-27 |
1993-02-02 |
Schering Aktiengesellschaft |
Formulation processes for pharmaceutical compositions of recombinant β-
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
JPS6475433A
(en)
*
|
1987-09-16 |
1989-03-22 |
Teijin Ltd |
Remedy for herpes simplex virus infection
|
|
ZA888577B
(en)
*
|
1987-11-27 |
1989-08-30 |
Akzo Nv |
Stabilization of antibodies
|
|
US5091313A
(en)
|
1988-08-05 |
1992-02-25 |
Tanox Biosystems, Inc. |
Antigenic epitopes of IgE present on B cell but not basophil surface
|
|
US5720937A
(en)
|
1988-01-12 |
1998-02-24 |
Genentech, Inc. |
In vivo tumor detection assay
|
|
EP0420937B1
(en)
|
1988-06-21 |
1994-11-09 |
Genentech, Inc. |
Therapeutic compositions for the treatment of myocardial infarction
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
US5945098A
(en)
*
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
AU2309692A
(en)
*
|
1991-07-03 |
1993-02-11 |
Cryolife, Inc. |
Method for stabilization of biomaterials
|
|
CA2113813C
(en)
|
1991-08-14 |
2005-04-12 |
Paula M. Jardieu |
Immunoglobulin variants for specific fc epsilon receptors
|
|
DE69232137T2
(de)
|
1991-11-25 |
2002-05-29 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
WO1994004188A1
(en)
|
1992-08-21 |
1994-03-03 |
Genentech, Inc. |
Method for treating an lfa-1-mediated disorder
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
WO1994012158A1
(en)
|
1992-12-02 |
1994-06-09 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
DK0733207T3
(da)
|
1993-12-10 |
1998-04-20 |
Genentech Inc |
Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
|
|
DK0739214T3
(da)
|
1994-01-18 |
1998-10-07 |
Genentech Inc |
Fremgangsmåde til behandling af parasitinfektionerunder anvendelse af IgE antagonister
|
|
US5702946A
(en)
|
1994-03-03 |
1997-12-30 |
Genentech, Inc. |
Anti-IL-8 monoclonal antibodies for treatment of inflammatory disorders
|
|
DK0779806T3
(da)
|
1994-09-09 |
2000-11-27 |
Takeda Chemical Industries Ltd |
Præparat til forsinket frigivelse indeholdende et metalsalt af et peptid
|
|
IL117645A
(en)
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
AU6267896A
(en)
|
1995-06-07 |
1996-12-30 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth oftumors
|
|
NZ310644A
(en)
|
1995-06-07 |
1999-08-30 |
Alkermes Inc |
Composition for sustained release of human growth hormone
|
|
ZA965368B
(en)
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
IL125255A
(en)
|
1996-01-23 |
2002-02-10 |
Genentech Inc |
Anti-cd18 antibodies for treating stroke
|
|
US7147851B1
(en)
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
|
WO1998023761A1
(en)
|
1996-11-27 |
1998-06-04 |
Genentech, Inc. |
HUMANIZED ANTI-CD11a ANTIBODIES
|
|
US6037454A
(en)
|
1996-11-27 |
2000-03-14 |
Genentech, Inc. |
Humanized anti-CD11a antibodies
|
|
JP3957765B2
(ja)
|
1997-04-07 |
2007-08-15 |
ジェネンテク・インコーポレイテッド |
抗ｖｅｇｆ抗体
|
|
EP0981618B2
(en)
|
1997-05-15 |
2011-08-24 |
Genentech, Inc. |
Anti-apo-2 antibody
|
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
|
US6946129B1
(en)
|
1999-06-08 |
2005-09-20 |
Seattle Genetics, Inc. |
Recombinant anti-CD40 antibody and uses thereof
|
|
CA2376596C
(en)
|
1999-06-25 |
2009-10-06 |
Genentech, Inc. |
Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
|
|
AU1071701A
(en)
*
|
1999-09-29 |
2001-04-30 |
Trustees Of The University Of Pennsylvania, The |
Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor
|
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
AU778199B2
(en)
|
1999-10-29 |
2004-11-25 |
Genentech Inc. |
Anti-prostate stem cell antigen (PSCA) antibody compositions and methods of use
|
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
AU2002213441B2
(en)
|
2000-10-12 |
2006-10-26 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
US7321026B2
(en)
|
2001-06-27 |
2008-01-22 |
Skytech Technology Limited |
Framework-patched immunoglobulins
|
|
EP1507793A4
(en)
|
2001-10-17 |
2006-02-01 |
Human Genome Sciences Inc |
NEUTROKIN ALPHA AND NEUTROKIN ALPHA SPLICE VERSION
|
|
US20040093621A1
(en)
|
2001-12-25 |
2004-05-13 |
Kyowa Hakko Kogyo Co., Ltd |
Antibody composition which specifically binds to CD20
|
|
KR101033196B1
(ko)
|
2002-02-14 |
2011-05-09 |
이뮤노메딕스, 인코오포레이티드 |
항-ｃｄ20 항체 및 그 융합 단백질 및 이들의 이용방법
|
|
CN101928344B
(zh)
|
2002-10-17 |
2014-08-13 |
根马布股份公司 |
抗cd20的人单克隆抗体
|
|
EP3263596A1
(en)
|
2002-12-16 |
2018-01-03 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
CN1798575A
(zh)
*
|
2003-04-04 |
2006-07-05 |
健泰科生物技术公司 |
高浓度抗体和蛋白制剂
|
|
US20050158303A1
(en)
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
|
CA2525251C
(en)
|
2003-05-09 |
2015-10-27 |
Duke University |
Cd20-specific antibodies and methods employing same
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
BRPI0414970A2
(pt)
*
|
2003-06-24 |
2012-12-11 |
Baxter Int |
método para transporte de drogas ao cérebro
|
|
US20050079184A1
(en)
|
2003-08-08 |
2005-04-14 |
Immunomedics, Inc. |
Bispecific antibodies for inducing apoptosis of tumor and diseased cells
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
JO3000B1
(ar)
*
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
NZ563370A
(en)
|
2005-06-20 |
2010-10-29 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
|
CN101237881B
(zh)
*
|
2005-08-03 |
2015-04-22 |
伊缪诺金公司 |
免疫偶联物剂型
|
|
WO2007019232A2
(en)
*
|
2005-08-03 |
2007-02-15 |
Immunogen, Inc. |
Immunoconjugate formulations
|
|
WO2009090189A1
(en)
*
|
2008-01-15 |
2009-07-23 |
Abbott Gmbh & Co.Kg |
Powdered protein compositions and methods of making same
|
|
BRPI0918978A2
(pt)
*
|
2008-09-10 |
2015-12-01 |
Genentech Inc |
composições e métodos a prevenção da degradação oxidativa das proteínas
|
|
AR076640A1
(es)
|
2009-03-06 |
2011-06-29 |
Genentech Inc |
Formulacion con anticuerpo. metodo para estabilizar anticuerpo. articulo de manufactura
|
|
CN104998269B
(zh)
*
|
2010-03-22 |
2019-06-11 |
弗·哈夫曼-拉罗切有限公司 |
对于稳定含有蛋白质的制剂有用的组合物和方法
|
|
RU2013155695A
(ru)
*
|
2011-06-30 |
2015-08-10 |
Дженентек, Инк. |
Препараты антител против с-мет
|
|
WO2015198451A1
(ja)
|
2014-06-26 |
2015-12-30 |
楽天株式会社 |
情報処理装置、情報処理方法及び情報処理プログラム
|